BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18985566)

  • 1. [Economy and medicine in haematology and oncology].
    Krych M; Ostermann H
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2115-8. PubMed ID: 18985566
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis-related groups as an instrument to develop suitable case-based lump sums in hematology and oncology].
    Thalheimer M
    Onkologie; 2011; 34 Suppl 1():11-5. PubMed ID: 21389763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Workshop - economic governance mechanisms : for Hematology and Oncology].
    Strech D; Deh U; Schmitz S; Gürkan I; Ostermann H; Krause SW
    Oncol Res Treat; 2015; 38 Suppl 1():3-22. PubMed ID: 25676572
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology].
    Creutzig U; Jürgens H; Herold R; Göbel U; Henze G
    Klin Padiatr; 2004; 216(6):379-83. PubMed ID: 15565554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Forward].
    Freund M; Lüftner D; Wilhelm M
    Oncol Res Treat; 2015; 38 Suppl 1():1. PubMed ID: 25676571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interest in and limitations of economic assessment applied to the evaluation of medical strategies: examples in oncological hematology].
    Moatti JP
    Therapie; 2001; 56(2):135-8. PubMed ID: 11471364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with the G-DRG-system five years after its introduction, as assessed by the Society of Pediatric Oncology and Hematology (GPOH)].
    Göbel U; Jürgens H; Christaras A; Berthold F; Klingebiel T
    Klin Padiatr; 2007; 219(6):303-5. PubMed ID: 18050038
    [No Abstract]   [Full Text] [Related]  

  • 8. [View].
    Freund M; Lüftner D; Wilhelm M
    Oncol Res Treat; 2015; 38 Suppl 1():23. PubMed ID: 25676573
    [No Abstract]   [Full Text] [Related]  

  • 9. [Benefit-risk evaluation of new drugs as a basis for decisions on prioritization in hematology/oncology: methodical challenges and problem-solving strategies].
    Ludwig WD; Schildmann J
    Onkologie; 2011; 34 Suppl 1():6-10. PubMed ID: 21389762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of cancer care: issues and implications.
    Meropol NJ; Schulman KA
    J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pediatric hematology and oncology in Germany: On the verge of a new reimbursement system].
    Berthold F; Herold R
    Klin Padiatr; 2002; 214(4):145-8. PubMed ID: 12165892
    [No Abstract]   [Full Text] [Related]  

  • 12. Can we afford the war on cancer?
    Szucs TD
    Onkologie; 2008 Mar; 31(3):81. PubMed ID: 18322408
    [No Abstract]   [Full Text] [Related]  

  • 13. Counting the costs of cancer care.
    Lyman GH
    Lancet Oncol; 2013 Nov; 14(12):1142-3. PubMed ID: 24131613
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer in Botswana: resources and opportunities.
    Suneja G; Ramogola-Masire D; Medhin HG; Dryden-Peterson S; Bekelman JE
    Lancet Oncol; 2013 Jul; 14(8):e290-1. PubMed ID: 23816293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Scientific results in paediatric oncology and haematology].
    Göbel U; Kulozik AE
    Klin Padiatr; 2004; 216(6):301-3. PubMed ID: 15565544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent advances in haematology and oncology].
    Jäger U; Hiddemann W
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2077. PubMed ID: 18985558
    [No Abstract]   [Full Text] [Related]  

  • 17. [DRG and nursing diagnoses--a catalogue analysis based on ICD-10-GM and OPS: reimbursing the total treatment case].
    Schanz B; Schreiber E
    Pflege Z; 2008 May; 61(5):265-8. PubMed ID: 18552113
    [No Abstract]   [Full Text] [Related]  

  • 18. [Haematology and oncology: in the vanguard of modern medicine].
    Ho AD; Hiddemann W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1921. PubMed ID: 19760550
    [No Abstract]   [Full Text] [Related]  

  • 19. StatBite: Survey: Oncologists on Costs and Treatment.
    J Natl Cancer Inst; 2009 Nov; 101(21):1443. PubMed ID: 19828872
    [No Abstract]   [Full Text] [Related]  

  • 20. Denis Burkitt and his contribution to haematology/oncology.
    Coakley D
    Br J Haematol; 2006 Oct; 135(1):17-25. PubMed ID: 16939495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.